Skip to main content

Advertisement

SpringerLink
Log in

Acute hepatitis associated with use of paroxetine

  • CE - Letter to the Editor
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Odeh M, Misselevech I, Boss JH, Oliven A (2001) Severe hepatotoxicity with jaundice associated with paroxetine. Am J Gastroenterol 96:2494–2496

    Article  PubMed  CAS  Google Scholar 

  2. Azaz-Livshits T, Hershko A, Ben-Chetrit E (2002) Paroxetine-associated hepatotoxicity: a report of 3 cases and a review of the literature. Pharmacopsychiatry 35:112–115

    Article  PubMed  CAS  Google Scholar 

  3. Colakoglu O, Tankurt E, Unsal B et al. (2005) Toxic hepatitis associated with paroxetine. Int J Clin Pract 59:861–862

    Article  PubMed  CAS  Google Scholar 

  4. Naranjo CA, Busto U, Sellers EM et al. (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30:239–245

    Article  PubMed  CAS  Google Scholar 

  5. Collins JM (2002) Idiosyncratic drug toxicity. Chem Biol Interact 142:3–6

    Article  PubMed  CAS  Google Scholar 

  6. Petersen KU (2002) From toxic precursors to safe drugs. Mechanisms and relevance of idiosyncratic drug reactions. Arzneimittelforschung 52:423–429

    PubMed  CAS  Google Scholar 

  7. DeVane CL (2003) Pharmacokinetics, drug interactions, and tolerability of paroxetine and paroxetine CR. Psychopharmacol Bull 37(Suppl 1):29–41

    PubMed  Google Scholar 

  8. Sindrup SH, Brosen K, Gram LF (1992) Pharmacokinetics of the selective serotonin reuptake inhibitor paroxetine: nonlinearity and relation to the sparteine oxidation polymorphism. Clin Pharmacol Ther 51:288–295

    Article  PubMed  CAS  Google Scholar 

  9. Kaye CM, Addock RE, Langley PF et al. (1989) A review of the metabolism and pharmacokinetics of paroxetine in man. Acta Psychiatr Scand Suppl 350:60–75

    Article  PubMed  CAS  Google Scholar 

  10. Kraus MR, Schafer A, Faller H, Csef H, Scheurlen M (2002) Paroxetine for the treatment of interferon-alpha-induced depression in chronic hepatitis C. Aliment Pharmacol Ther 16:1091–1099

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Istituto di Medicina Interna e Geriatria, Università Cattolica del Sacro Cuore, Largo A. Gemelli, 8, 00168, Rome, Italy

    Maurizio Pompili, Paola Tittoto, Roberta Mascianà, Giovanni Gasbarrini & Gian Ludovico Rapaccini

Authors
  1. Maurizio Pompili
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paola Tittoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Roberta Mascianà
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Giovanni Gasbarrini
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gian Ludovico Rapaccini
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maurizio Pompili.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pompili, M., Tittoto, P., Mascianà, R. et al. Acute hepatitis associated with use of paroxetine. Intern Emerg Med 3, 275–277 (2008). https://doi.org/10.1007/s11739-008-0111-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-008-0111-9

Keywords

Search

Navigation